Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 834 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 511.80 USD | -0.96% | -0.43% | -7.78% | +20.82% | 11.82 B USD | ||
| 861 | TECH Bio-Techne Corp - Common Stock | 72.36 USD | +0.06% | -0.03% | +0.98% | +27.26% | 11.33 B USD | ||
| 876 | AXSM Axsome Therapeutics, Inc. - Common Stock | 206.30 USD | -0.71% | -3.80% | -14.20% | +58.45% | 10.81 B USD | ||
| 886 | CYTK Cytokinetics, Incorporated - Common Stock | 76.14 USD | -0.91% | +3.06% | -6.59% | +31.05% | 10.59 B USD | ||
| 898 | SMMT Summit Therapeutics Inc. - Common Stock | 12.46 USD | -5.32% | +2.13% | -10.04% | -37.26% | 9.94 B USD | ||
| 899 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 365.98 USD | -2.65% | -3.34% | +12.51% | +658.98% | 10.22 B USD | ||
| 919 | KRYS Krystal Biotech, Inc. - Common Stock | 344.62 USD | -0.57% | +3.76% | +1.63% | +84.16% | 10.20 B USD | ||
| 933 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.54 USD | -0.62% | +1.02% | +24.75% | +98.08% | 9.99 B USD | ||
| 936 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 151.51 USD | -1.82% | -2.06% | +11.31% | +101.66% | 9.80 B USD | ||
| 938 | KYMR Kymera Therapeutics, Inc. - Common Stock | 117.13 USD | -2.23% | -1.16% | +5.93% | +98.19% | 9.74 B USD | ||
| 940 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.33 USD | +0.99% | +6.63% | +6.59% | -16.35% | 10.03 B USD | ||
| 963 | SYRE Spyre Therapeutics, Inc. - Common Stock | 105.52 USD | -0.91% | +2.35% | +2.95% | +341.32% | 9.30 B USD | ||
| 969 | PCVX Vaxcyte, Inc. - Common Stock | 61.46 USD | -1.85% | +3.87% | +12.21% | +45.30% | 9.15 B USD | ||
| 978 | IMVT Immunovant, Inc. - Common Stock | 43.66 USD | -1.60% | +3.85% | +9.23% | +127.28% | 9.02 B USD | ||
| 987 | ABVX Abivax SA - American Depositary Shares | 113.87 USD | -0.94% | -5.55% | -9.58% | +47.73% | 8.94 B USD | ||
| 993 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.78 USD | +0.11% | +0.09% | +1.17% | +106.28% | 8.99 B USD | ||
| 1034 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.76 USD | +0.01% | +0.16% | +0.36% | +151.46% | 8.38 B USD | ||
| 1039 | TGTX TG Therapeutics, Inc. - Common Stock | 53.62 USD | -1.20% | +9.54% | -6.42% | +81.95% | 8.21 B USD | ||
| 1045 | IBRX ImmunityBio, Inc. - Common Stock | 7.55 USD | -3.08% | -1.31% | +3.99% | +226.84% | 8.00 B USD | ||
| 1079 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 110.40 USD | +0.36% | -5.27% | +5.50% | +0.08% | 7.60 B USD |
Nachrichten Biotechnology Stocks
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
H.C. Wainwright bekräftigt "Buy"-Rating für Biomea Fusion nach Meilenstein in Diabetes-Studie
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |